Safety and efficacy of implantable defibrillator therapy with programmed shock energy at twice the augmented step-down defibrillation threshold: results of the prospective, randomized, multicenter low-energy endotak trial

« Previous Next »American Journal of Cardiology
Volume 83, Issue 5, Supplement 2 , Pages 34-39, 11 March 1999

Safety and efficacy of implantable defibrillator therapy with programmed shock energy at twice the augmented step-down defibrillation threshold: results of the prospective, randomized, multicenter low-energy endotak trial☆

Joerg Neuzner, MD
- Kerckhoff Clinic, Bad Nauheim, Germany
- Address for reprints: Joerg Neuzner, MD, Department of Cardiology, Max Planck Institute for Physiological and Clinical Research, Kerckhoff Clinic, Benekestrasse 2–8, D-61231 Bad Nauheim, Germany
Andreas Liebrich, MD
- University Hospital, Johannes Gutenberg University, Mainz, Germany
Jens Jung, MD
- University Hospital, Saarland, Homburg-Saar, Germany
Ewald Himmrich, MD
- University Hospital, Johannes Gutenberg University, Mainz, Germany
Heinz F Pitschner, MD
- Kerckhoff Clinic, Bad Nauheim, Germany
Joachim Winter, MD
- University Hospital, Heinrich Heine University, Düsseldorf, Germany
Ernst G Vester, MD
- University Hospital, Heinrich Heine University, Düsseldorf, Germany
Ulrich Michel (BSBME)
- Guidant Europe, Zaventem, Germany
Seah Nisam (BSEE)
- Guidant Europe, Zaventem, Germany
Armin Heisel, MD
- University Hospital, Saarland, Homburg-Saar, Germany